These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mycophenolate Mofetil for Immune Thrombocytopenia. Reply. Bradbury CA; Hill Q; Greenwood R N Engl J Med; 2021 Dec; 385(23):2201-2202. PubMed ID: 34874644 [No Abstract] [Full Text] [Related]
5. Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia. Bradbury CA; Pell J; Hill Q; Bagot C; Cooper N; Ingram J; Breheny K; Kandiyali R; Rayment R; Evans G; Talks K; Thomas I; Greenwood R N Engl J Med; 2021 Sep; 385(10):885-895. PubMed ID: 34469646 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. Howard J; Hoffbrand AV; Prentice HG; Mehta A Br J Haematol; 2002 Jun; 117(3):712-5. PubMed ID: 12028047 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of mycophenolate mofetil in a child with refractory Evans syndrome. Guirat-Dhouib N; Mellouli F; Kouki R; Bejaoui M J Pediatr Hematol Oncol; 2010 Aug; 32(6):e244. PubMed ID: 20628320 [No Abstract] [Full Text] [Related]
8. Successful handling of autoimmunity in X-linked thrombocytopenia (XLT) using mycophenolate mofetil. Casimiro A; Almeida T; Freitas O; Cordeiro AI; Neves C; Neves JF Pediatr Blood Cancer; 2012 Nov; 59(5):961. PubMed ID: 22692965 [No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil as an alternative to cyclosporine in post renal transplant thrombocytopenia. Phadke K; Bagirath A Pediatr Nephrol; 2004 Jul; 19(7):822-3. PubMed ID: 15141344 [No Abstract] [Full Text] [Related]
10. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs. Cummings FO; Rizzo SA J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307 [TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil therapy for severe immune thrombocytopenia. Taylor A; Neave L; Solanki S; Westwood JP; Terrinonive I; McGuckin S; Kothari J; Cooper N; Stasi R; Scully M Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874 [TBL] [Abstract][Full Text] [Related]
13. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil. Vasoo S; Thumboo J; Fong KY Lupus; 2003; 12(8):630-2. PubMed ID: 12945723 [TBL] [Abstract][Full Text] [Related]
14. Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial. Pell J; Greenwood R; Ingram J; Wale K; Thomas I; Kandiyali R; Mumford A; Dick A; Bagot C; Cooper N; Hill Q; Bradbury CA BMJ Open; 2018 Oct; 8(10):e024427. PubMed ID: 30341143 [TBL] [Abstract][Full Text] [Related]
15. Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report. Bruserud Ø; Håvardstein K Hematology; 2009 Aug; 14(4):224-6. PubMed ID: 19635186 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. Provan D; Moss AJ; Newland AC; Bussel JB Am J Hematol; 2006 Jan; 81(1):19-25. PubMed ID: 16369979 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura. Ahmad HN; Thomas-Dewing RR; Hunt BJ Eur J Haematol; 2007 May; 78(5):449-52. PubMed ID: 17331134 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura. Zhang WG; Ji L; Cao XM; Chen YX; He AL; Liu J; Zhao WH; Zou SP Acta Pharmacol Sin; 2005 May; 26(5):598-602. PubMed ID: 15842780 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura. Ogimi C; Honma N; Tanaka R; Oh-ishi T Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356 [TBL] [Abstract][Full Text] [Related]
20. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Arnold DM; Nazi I; Santos A; Chan H; Heddle NM; Warkentin TE; Kelton JG Blood; 2010 Jan; 115(1):29-31. PubMed ID: 19897578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]